from

From AI to Creativity: The ToyTrends for Spielwarenmesse 2026

"AI Loves (to) Play": Intelligent toys for interactive play experiences "Creative Mindfulness": Creative activities, creating special moments NUREMBERG, Germany, Oct.…

4 months ago

Authors, Publishers, and Copyright Owners May Benefit from a $1.5 Billion Class Action Settlement

SEATTLE, Oct. 7, 2025 /PRNewswire/ -- JND Legal Administration A proposed class action settlement was reached in the lawsuit, Bartz v.…

4 months ago

Trinasolar Vertex N Shield module wins comprehensive reliability award from TV Rheinland

CHANGZHOU, China, Sept. 30, 2025 /PRNewswire/ -- Trinasolar announced its Vertex N Shield module has been honored with the PV…

4 months ago

Elham Tea House Receives Highly Recommended Rating from Renowned Tea Room Expert

Wednesday 1 October, 2025 The Elham Tea House, a charming establishment nestled in the heart of Elham village and proudly…

5 months ago

Deals Exceeding RMB 2 Billion Follow SANY’s Showcase of Integrated Green Solutions at Mining Indonesia 2025

BEIJING, Sept. 30, 2025 /PRNewswire/ -- From September 17 to 20, 2025, SANY Group presented its latest large-scale mining equipment and…

5 months ago

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

September 29, 2025 19:30 ET  | Source: Nxera Pharma Tokyo, Japan and Cambridge and London, UK, 30 September 2025 –…

5 months ago

Abu Dhabi Art Fair 2025 to Host 140 Galleries From 35+ Countries

ABU DHABI, UAE, Sept. 29, 2025 /PRNewswire/ -- Organised by the Department of Culture and Tourism – Abu Dhabi (DCT…

5 months ago

Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital

LONDON, ROME and ZUG, Switzerland, Sept. 29, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN)…

5 months ago

OXCCU Raises $28m in Series B Funding to Scale Sustainable Aviation Fuel from Waste Carbon

Backed by global leaders in aviation, energy, and climate investing, OXCCU strengthens its position as a critical player in the global…

5 months ago

Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025

NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer…

5 months ago